Loading clinical trials...
Loading clinical trials...
Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump, Cetaphil® DermaControl™ Moisturizer SPF 30, and Cetaphil® DermaControl™ Foam Wash Regimen in Student Athletes With Mild to Moderate Acne Vulgaris
Conditions
Interventions
Adapalene/benzoyl peroxide gel, 0.1%/2.5%
Cetaphil Acne Regimen
Locations
1
United States
Pflugerville Dermatology Clinical Research
Pflugerville, Texas, United States
Start Date
August 1, 2014
Primary Completion Date
February 1, 2015
Completion Date
February 1, 2015
Last Updated
August 23, 2022
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions